Icon Cancer Centre South Brisbane

South Brisbane, Queensland QLD 4101

4 studies enrolling now · 11 studies all time

What they study most

Abiraterone Acetate, Advanced Malignancies, Advanced Solid Tumor, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Cytochrome P-450

Studies at this site

• A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors — Recruiting now
• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer — Recruiting now
• A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors — Recruiting now
• A Study of DM001 in Patients With Advanced Solid Tumors — Recruiting now
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors — Stopped early
• A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors — Stopped early
• A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer — Running, not enrolling
• Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors — Completed